Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added study locations in California, Florida, and Georgia. Updated page to revision v3.3.3 on 2025-12-22.
    Difference
    0.7%
    Check dated 2025-12-23T22:32:10.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    These changes update the Publications section to say publications are automatically filled from PubMed, and update the page revision to v3.3.2. They do not affect the study data, eligibility criteria, or locations.
    Difference
    0.1%
    Check dated 2025-11-25T13:43:06.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The government funding status notice at the top of the page was removed. No study details, eligibility criteria, or results were changed.
    Difference
    0.4%
    Check dated 2025-11-18T07:21:51.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now displays branding for the Moffitt Cancer Center and Research Institute and includes a Helpful Links section.
    Difference
    0.2%
    Check dated 2025-11-11T03:02:02.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page shows updated study record dates, including the last update and results posting dates. Core study details such as completion status and locations appear current.
    Difference
    0.4%
    Check dated 2025-11-03T21:24:44.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating status details for the NIH Clinical Center, plus a link to relevant official sites. - Upgraded version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T05:59:49.000Z thumbnail image

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.